Tonalin CLA

by Bronson Laboratories · softgel capsule · 90 softgels

  • On the market (NIH)
  • UPC 7 16563 21101 1
  • DSLD label 257446
  • Serving 2 softgels
  • 45 servings

Tonalin CLA by Bronson Laboratories lists one ingredient: 2,000 mg of tonalin safflower oil per serving of 2 softgels. Its current label entered the NIH Dietary Supplement Label Database on December 18, 2021.

What is in Tonalin CLA?

Each row as the label prints it, per serving of 2 softgels. The capsule beside an amount places it among every product in the NIH database that lists the same ingredient: the bar is the middle half of their amounts, the line in it the median, the whiskers the 10th and 90th percentiles; the green tick is the FDA Daily Value and the red dashed tick the adult upper limit (IOM).

Tonalin CLA: Supplement Facts rows against the market (DSLD label 257446, January 2026 release)
IngredientAmount% DVAmong products listing it
Calories20 Calories
Calories from Fat20 Calories
Total Fat2 g3%Fat (unspecified) in Tonalin CLA against 11,965 products2 g per serving; the middle half of products list 1 g to 2.5 g, the median 1.5 g.2 g

Higher than 56% of 11,965 products listing fat (unspecified) (median 1.5 g). Per day at the most servings: 4 g.

Tonalin Safflower Oilas Conjugated Linoleic Acid2,000 mgSafflower Oil in Tonalin CLA against 101 products2 g per serving; the middle half of products list 1 g to 2 g, the median 1.25 g.2 g

Higher than 70% of 101 products listing safflower oil (median 1.25 g). Per day at the most servings: 4 g.

Source: NIH ODS Dietary Supplement Label Database, label 257446 (entered December 18, 2021), version 9.4.0. See the label on DSLD. Amounts are what the maker printed; DSLD does not test products. Daily Values: the FDA's Daily Value page.

Is that a lot?

Every amount on this label with a position sits within the middle 80% of the products that list the same ingredient.

The NIH database records 2 servings a day from the label's directions; its % Daily Values are for adults and children 4 or more years of age. The directions as printed are further down this page.

The Tolerable Upper Intake Level is the most of a nutrient per day, from food, water and supplements together, that is likely to pose no risk for almost all adults (Institute of Medicine, 2011). It does not apply under medical supervision. This page compares labels; it is not medical advice.

Sources: amounts from the DSLD label; Daily Values from 21 CFR 101.9(c)(8)(iv); adult upper limits from the Institute of Medicine's DRI summary tables (2011). How positions are computed.

Which products have the closest formulas?

6 products list the very same ingredients; the nearest amounts come first.

Source: ingredient lists of every product's current label in DSLD (version 9.4.0); similarity weights each shared ingredient by how rare it is.

What does the label say about taking it?

Quoted from the label as DSLD transcribed it: the maker's words, including any claim about what the product does, which the FDA has not evaluated and PlainVitamins does not endorse.

Directions
Directions: As a dietary supplement for adults, take 2 softgels two times daily, preferably with a meal or as directed by a healthcare professional.
Warnings
Warning: Consult a healthcare professional before taking this product if you are pregnant or nursing.
Keep out of reach of children.
Storage
Store at room temperature. Protect from light.

Source: label statements in DSLD label 257446.

What else is on the label?

Other ingredients: Gelatin, Vegetable Glycerin, natural Caramel color, Water, Purified.

How many labels does Tonalin CLA have?

One label is on file, entered on December 18, 2021.

  1. Label 257446 (current) Entered December 18, 2021 · on the market · 90 softgels · UPC 7 16563 21101 1

DSLD also links this label to: Cla (image difference, same product).

Source: DSLD label entry and market events, version 9.4.0 (labels entered through September 25, 2025).

Who makes it?

The label names Bronson Laboratories (manufacturer), Lindon, UT. All Bronson Laboratories products.

Where next?